Top of this page
Skip navigation, go straight to the content
Welcome to
UCB investor relations
Our Investor Relations team aim to serve analysts, shareholders and potential investors with timely, valuable and reliable information.
Corporate events›
| Date | Event details |
|---|---|
| 26 April 2012 | Interim report3-month interim report - press release only |
| 01 August 2012 | 2012 half-year financial results |
IR events
| Date | Event details |
|---|---|
| 30 May 2012 | Roadshow in FrankfurtUCB will be on the road with Kepler |
| 05 June 2012 | Goldman Sachs conference - CaliforniaPresentation & 1/1 meetings |
| 06 June 2012 | Goldman Sachs conference - California1/1 meetings |
News list ›
- Acquisition of own shares in the framework of employees’ long-term incentive plans 10-May-2012
- First stone in UCB’s new Swiss biotechnology production unit to be set 04-May-2012
- Acquisition of own shares in the framework of employees’ long-term incentive plans 03-May-2012
- UCB moving ahead to become patient-centric biopharmaceutical leader 26-Apr-2012
More information
2011 performances by
Roch Doliveux
Magazine›
-
2012 gets off on the right foot
2012 gets off on the right foot
Posted by Antje Witte, Investor Relations 26-Apr-2012
-
Introducing the UCB Annual Report 2.0
Introducing the UCB Annual Report 2.0
Posted by Isabelle Ghellynck, Investor Relations 08-Mar-2012
-
2011 was a good year for UCB
2011 was a good year for UCB
Posted by Antje Witte, Investor Relations 02-Mar-2012
Last year was another good one - paving the way for sustainable company growth
